Risks and Indications for RBCs Transfusions David Stroncek, MD Chief, Laboratory Services Section Department of Transfusion Medicine, Clinical Center,

Slides:



Advertisements
Similar presentations
Transfusion-Related Acute Lung Injury
Advertisements

Adverse Effects of Blood Transfusion. Adverse Effects of Blood Transfusion ANY unfavorable consequence is considered an adverse effect of blood transfusion.
Physiology of Acute Anemia John R. Feiner, MD Department of Anesthesia and Perioperative Care University of California, San Francisco.
Blood Transfusion in The Neonate Dr.Boskabadi Neonatologist.
Pablo M. Bedano M.D. Community Regional Cancer Care.
Hematology The Study of Blood Blood contains cells, proteins, and sugars Red blood cells transport oxygen- erythrocytes White blood cells are part of the.
INDICATIONS FOR EMERGENT TRANSFUSIONS Manjushree Matadial DO Saint Joseph Hospital and Medical Center, April 27,2009.
Spotlight Case Transfusion Overload. 2 Source and Credits This presentation is based on the November 2012 AHRQ WebM&M Spotlight Case –See the full article.
THE TRISS TRIAL Holst, L et al. Lower versus Higher Hemoglobin Threshold for Transfusion in Septic Shock. New England Journal of Medicine October 9, 2014.
1 Proposed Changes to ICD-9-CM Transfusion Associated Adverse Events September 17th, 2009 ICD-9-CM Coordination and Maintenance Committee Meeting Mikhail.
Single-Donor Platelets: Arguments for Preferential Use Paul M. Ness, MD Transfusion Medicine Division Johns Hopkins Medical Institutions.
Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric.
Transfusion Trends In Surgical Patients
Is that Hemoglobin High Enough? COPYRIGHT © 2014, ALL RIGHTS RESERVED From the Publishers of.
بسم الله الرحمن الرحيم. Ahmad Shihada Silmi,Msc, FIBMS Lecturer of Haematology & Immunology Faculty of Science, IUG Autologous Blood BY.
4th year medical students 2nd Feb,2008 Transfusion Medicine III Complications and Safety of Transfusion Practices Salwa Hindawi Medical Director of Blood.
Hepatitis in a surgeon- problem oriented learning: Part I Paul Froom MD, MOccH Chief of Epidemiology Israel- National Institute of Occupational and Environmental.
Transfusion of Blood Product History: 1920:Sodium citrate anticoagulant(10 days storage) 1958: Plastic bag of transfusion 1656: Initial theory and.
Transfusion Related Acute Lung Injury (TRALI): Clinical and Laboratory Aspects David Stroncek, MD Chief, Laboratory Services Section Department of Transfusion.
Cardiorespiratory Adaptations to Training
Unit #5B – Clinical Laboratory Testing Basic Hematology Cecile Sanders, M.Ed., MLS(ASCP)
Red cells and the critically ill patient “Conservatives” or “Liberals” Dr A. Surekha Devi Consultant, Transfusion Medicine Hyderabad.
+ Dr. Megan Rowley Consultant in Transfusion Medicine Blood Transfusion.
TRANSFUSION SAFETY AN INTERNATIONAL FLAVOR. RISK DATA – U.S. Motor cycling 1:50 20 Cigarettes/d 1:200 Hit by car 1:20,000 BC pills 1:50,000 Earthquake.
What Is the Difference Between Blood and Chicken Soup?
BLOOD COMPONENT THERAPY FOR THE NEONATE
BLOOD TRANSFUSION BRI BUDLOVSKY R3 JANUARY OVERVIEW The process Blood components Testing Consent Transfusion reactions.
The New Priority: Decreasing Readmissions after Cardiothoracic Surgery: How Do We Get There? Michael Zhen-Yu Tong, MD, MBA Department of Cardiothoracic.
Why Special Blood Products?
Blood Transfusion in Acute Trauma
BLOOD TRANSFUSIONS Dr. Tamara Wagenheim.
Blood Transfusion Done by : Mrs.Eman Rizk. Definition ( Blood Transfusion ) Is the process of transferring blood or blood-based products from one person.
Red Cell Transfusion in Critical Care Patients Alan Tinmouth, MD MSc University of Ottawa Centre for Transfusion Research, Ottawa Health Research Institute.
Transfusion Therapy Principles of IV Therapy BSN336.
Blood Component Therapy
Reduction of RBC transfusions based on standardized hemoglobin evaluation for adult non-ICU patients Kathryn Curcione RN, BSN, ONC, NE-BC, Molly Rankin,
Pediatric Septic Shock
Monthly Journal article review: Vimmi Kang PGY 2
MASSIVE TRANSFUSION OB ROUNDS, JAN RECOMMENDATIONS FOR MASSIVE TRANSFUSION Assuming: Previously healthy 70 kg adult No cardiac disease Not anaemic.
Lecture 2 Red Blood Cells, Anemias & Polycythemias
Transfusion Reactions
Blood component therapy This is the seperation of whole blood into its individual components to optimize individual therapeutic potency based on sound.
TRANSPORT IN PLANTS AND ANIMALS BLOOD GROUPS AND BLOOD TRANSFUSION Lesson objectives; By the end of the lesson the learner should be able to explain the.
Age of Transfused Blood: Short-Term Mortality and Long-Term Survival after Cardiac Surgery Mark Stafford-Smith, MD, CM, FRCPC, FASE Professor of Anesthesiology.
Module 8: Alternative strategies to transfusion Transfusion Training Workshop KKM 2012.
Chapter 19 Blood.
Impact of a PRUDENT © Red Blood Cell Transfusion Strategy in Pediatric HSCT and Oncology Patients Results from the CHB Experience © 2009 All rights.
The complications can be broadly classified into two categories: Immune Complications Non-immune Complications.
Transfusion Related Acute Lung Injury (TRALI)
BLOOD TRANSFUSION Ferdi Menda,M.D. Associated Prof of Anesthesiology Yeditepe University.
BLOOD TRANSFUSION Ferdi Menda,M.D. Assistant Prof of Anesthesiology Yeditepe University.
MLAB Hematology Keri Brophy-Martinez
Ann Intern Med. 2012;157(1): doi: / Figure Legend:
Blood Transfusion Reaction in neonates & management
Miscellaneous Topics in Transfusion
Transfusion thresholds for cancer patients
TRANSFUSION REACTIONS
Surgical ICU, Heart Institute University of São Paulo
Blood transfusion: When to transfuse and risks involved
Indication of Blood Transfusion in Newborns Dr Bijan Keikhaei Full Professor of Pediatric Hematology and Oncology Research Center for Thalassemia and.
Transfusion Medicine Kristine Krafts, M.D..
BLOOD COMPONENTS TRANSFUSION INDICATIONS
Benefits of autotransfusion
Blood Transfusion Evidence-Based Blood Therapeutics “7 is the NEW 10”
PRBC Transfusions Medicine Floors Internal Medicine, PGY-3
Unit #6B – Clinical Laboratory Testing Basic Hematology
Monthly Journal article review: Vimmi Kang PGY 2
Transfusion Medicine Kristine Krafts, M.D..
Blood Basics.
Presentation transcript:

Risks and Indications for RBCs Transfusions David Stroncek, MD Chief, Laboratory Services Section Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, Maryland

Adverse Effects of RBC Transfusions Viral Infections Hepatitis B Hepatitis C HIV HTLV I and II West Nile Virus CMV

Risk of Transfusion-Transmitted Infections 2002 USA Canada 2 HBV1:205,0001:153,000 HCV1:1,935,0001:2,300,000 HIV1:2,135,0001:7,800,000 HTLV1:2,993,0001:4,300, Dodd RY et al. Transfusion. 2002;42: O'Brien SF et al.Transfusion. 2007;47:316-25

Adverse Effects of RBC Transfusions Other pathogens Bacteria Malaria Chagas Babesia

Adverse Effects of RBC Transfusions Hemolytic Transfusion Reactions ABO (wrong unit of blood) Antibodies to other RBC antigens (delayed hemolytic transfusion reactions) Leukocyte antibody mediated problems Alloimmunization (refractory to platelet transfusions) Febrile reactions (antibody in transfusion recipient) Transfusion related acute lung injury (TRALI) (antibody in blood donor)

Adverse Effects of RBC Transfusions Other Fluid overload Anaphylaxis Urticaria GVHD Immune modulation

Transfusion Fatalities Reported to the FDA (FY 2004 to 2006)

Function of RBCs Oxygen Transport Delivery of oxygen from lungs to tissues Oxygen transport is dependent on Hematocrit Cardiac output Oxygen extraction

Normovolemic Amenia As hematocrit falls Blood viscosity decreases Cardiac output increases (  Stroke volume,  pulse) Delivery of O 2  O 2 extraction  Consumption of O 2 remains constant

Limits of Compensation At very low hemoglobin levels (approximately 4 g/dL) O 2 delivery does not meet demand Anerobic metabolism  lactic acidosis  cardiac arrest

Indications for RBC transfusions 1940s Recommended that surgery patients have a hemoglobin of 8 to 10 g/dL Led to a general rule of hemoglobin > 10 g/dL of surgery patients 1980s Development of invasive monitoring techniques lead to a better understanding of oxygen delivery and consumption Lower hemoglobin levels could be tolerated

Hemoglobin and Hematocrit Levels in Healthy Adults Hemoglobin (g/dL) Hematocrit (%) Mean-2SDMean-2SD Female Male Hematology: Basic Principles and Practice. Elsevier 2005

Transfusion Trigger: Multicenter, Randomized Control Study of ICU Patients Transfusion Strategy Hb Trigger Maintenance Level Conservative7.0 g/dL7.0 to 9.0 g/dL Liberal10.0 g/dL10.0 to 12.0 g/dL Herbert PC et al. N Engl J Med. 1999;340:

Transfusion Trigger: Multicenter, Randomized Control Study of ICU Patients 30-day mortalityP Restrictive18.7%0.11 Liberal23.3% Less acutely ill 30-day mortalityP Restrictive8.7%0.03 Liberal16.1% Cardiac disease patient 30-day mortalityP Restrictive20.5%0.69 Liberal22.9% Herbert PC et al. N Engl J Med. 1999;340:

Restrictive vs Liberal Transfusion in Other Conditions No difference Pediatric ICU patients 7.0 g/dL vs 9.5 g/dL Lacroix J, et al. N Engl J Med. 2007:356; Moderate to severe head injury 7.0 g/dL vs 10.0 g/dL McIntyre LA et al. Neutrocrit Care 2006;5:4-9 Possible difference Cardiovascular disease 7.0 g/dL vs 10.0 g/dL Liberal transfusions may be better in patients with acute myocardial infarction and unstable angina Hebert PC et al. Crit Care Med. 2001;29:

Optimal Hematocrit? Laboratory and mathematical model Maximize delivery of oxygen O 2 delivery is proportional to hematocrit and blood flow rate. As hematocrit increases viscosity increases and flow rate decrease Optimal hematocrit is approximately 35% Crowell JW and Smith EE. J Appl Physiol 1967;22: Clinical Risks associated with increasing the hemoglobin/hematocrit justify the clinical benefits

Conclusions Although RBCs are much safer than 20 years ago, transfusion practices have become more restrictive The transfusion threshold at most institutions is a hemoglobin of 7 to 8 g/dL for most patients Higher thresholds are used for specific patients

Disclaimer The views expressed are those of the presenter and do not necessarily represent the position of the National Institutes of Health or the Department of Health and Human Services.